Embotelladora Andina S.A (ANDINA-B)
Santiago Stock Exchange · Chile · prices in CLP · close of 27 Oct 2026
Key indicators
| Last close | CLP 4,863.70 |
|---|---|
| 52-week range | 3,834.30 – 5,019.70 |
| Return, 1 month / 3 months | −1.7% / +6.6% |
| Return, 1 year / 3 years | +23.9% / +214.2% |
| Trend | Uptrend |
| RSI (14) | 53 |
| Volatility (1 year) | 27.2% |
| Worst drawdown (1 year) | -18.3% |
| Average daily value traded | 3,741.43M CLP |
| Dividend yield | 3.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Embotelladora Andina is a beverage bottler based in Chile that produces and distributes Coca-Cola brand soft drinks along with juices, bottled water and other non-alcoholic drinks. It serves retailers, restaurants, small shops and other outlets through its distribution networks, and it runs bottling plants and sales operations across several South American countries. The company works under franchise agreements with Coca-Cola and also markets its own lines of juices and waters to consumers in the region.
On this site Embotelladora Andina S.A appears as a stock on the Santiago Stock Exchange (Chile), code ANDINA-B, with prices in Chilean pesos (CLP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Embotelladora Andina S.A (ANDINA-B) trades on the Santiago Stock Exchange in Chile. It last closed at CLP 4,863.70 on 27 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 21 of 112 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 23.9% and over the last three months it rose 6.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Santiago Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.4% | ||
| From 52-week high | -2.3% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.6% | ||
| 6-month return | 12.3% | ||
| 12-month return, skipping the last month | 26.1% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.3% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 3,741.43M CLP | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.5% |
|---|---|
| 1 month | −1.7% |
| 3 months | +6.6% |
| 6 months | +12.3% |
| 1 year | +23.9% |
| 3 years | +214.2% |
| 5 years | +336.5% |
Signals
| 50-day / 200-day average | 4,750.85 / 4,406.13 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 131.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Aug 2026 | CLP 56.1000 |
| 11 May 2026 | CLP 112.2000 |
| 15 Dec 2025 | CLP 22.0000 |
| 20 Oct 2025 | CLP 38.5000 |
| 27 Jan 2025 | CLP 155.1000 |
| 21 Oct 2024 | CLP 35.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Santiago Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.